当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2014年第33期 > 正文
编号:12706890
肝样腺癌4例(4)
http://www.100md.com 2014年11月25日 黄明敏等
第1页

    参见附件。

     [12] Haninger DM,Kloecker GH,Bousamra M,et al. Hepatoid adenocarcinoma of the lung:report of five cases and review of the literature [J]. Mod Pathol,2014,27(4):535-542.

    [13] Fukunaga M,Fujiwara Y,Naito Z. Hepatoid carcinoma with serous component of the fallopian tube:a case report with immunohistochemical and ultrastructural studies [J]. Int J Gynecol Pathol,2006,25(3):233-237.

    [14] Osada M,Aishima S,Hirahashi M,et al. Combination of hepatocellular markers is useful for prognostication in gastric hepatoid adenocarcinoma[J]. Human Pathology,2014,45(6):1243-1250.

    [15] 姚敏,杨燕,姚登福,等.循环血单核细胞GPC-3mRNA和甲胎蛋白对肝癌诊断与转移监测的潜在价值[J].临床肝胆病杂志,2012,28(10):777-781.

    [16] 陈福真,李滨,许东辉.肝移植治疗胃肝样腺癌肝转移一例[J].中华器官移植杂志,2006,27(9):566-567.

    [17] Yasui W,Oue N,Sentani K,et al. Transcriptome dissection of gastric cancer:identification of novel diagnostic and therapeutic targets from pathology specimens[J]. Pathology International,2009,59(3):121-136.

    (收稿日期:2014-08-08 本文编辑:苏 畅)

您现在查看是摘要介绍页,详见PDF附件